CURTIN UNIVERSITY

CURTIN UNIVERSITY logo
🇦🇺Australia
Ownership
Private
Established
1986-01-01
Employees
1K
Market Cap
-
Website
http://www.curtin.edu.au
proactiveinvestors.com
·

Just the Facts: Prescient Therapeutics secures FDA approval for PTX-100 Phase 2 trials

Tylah Tully, a 2023 Curtin University graduate with degrees in International Business and Journalism, has a diverse journalism background. Proactive financial news provides global business and finance updates, focusing on medium and small-cap markets, biotech, mining, and emerging technologies. The publisher uses human expertise and technology, including AI, to enhance content production.

Just the Facts: Orthocell achieves FDA study milestone for Remplir™ nerve repair product

Tylah Tully, a 2023 Curtin University graduate with a double degree in International Business and Journalism, is an emerging broadcast journalist specializing in mining and stock markets. Proactive, the publisher, provides global finance news with teams in key finance hubs, focusing on medium and small-cap markets, and uses technology to enhance content production.
proactiveinvestors.com
·

Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US

Tylah Tully, a 2023 Curtin University graduate with a double degree in International Business and Journalism, specializes in mining and stock markets. Proactive financial news, with teams in major finance hubs, delivers independent, actionable content across various sectors. The publisher uses technology to enhance workflows, ensuring all content is human-authored.
newatlas.com
·

Alzheimer's drug trial raises concerns for accelerating cognitive decline

New research on deferiprone, an iron-reducing drug, shows it accelerates cognitive decline in Alzheimer’s patients despite lowering brain iron levels.
nature.com
·

Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon

The Undiagnosed Hackathon was conceptualized and designed by H.C., M. Cederroth, A.N., and A.M.D.V. Biological samples and phenotype data were collected by various authors, processed and analyzed under the coordination of A.M.D.V. et al. All authors participated in data analysis and interpretation, with A.M.D.V. et al. drafting the manuscript. A.N., H.C., and M. Cederroth secured funding.
proactiveinvestors.com
·

Recce Pharmaceuticals reaches midpoint in Phase II Trial for Topical Gel R327G

Tylah Tully, a 2023 Curtin University graduate with a double degree in International Business and Journalism, is an emerging broadcast journalist specializing in mining and stock markets. Proactive, the publisher, provides global investment news with teams in key finance hubs, using technology to enhance human-authored content.
© Copyright 2024. All Rights Reserved by MedPath